InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Patel Sandip I. Director active across 5 companies, notably Akari Therapeutics Plc. In total, 5 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €3k. History available since 9 March 2023. The latest transaction was disclosed on 6 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Patel Sandip I is a declarant and a director at Akari Therapeutics Plc, Peak Bio, Inc., AtlasClear Holdings, Inc., Quantum FinTech Acquisition Corp and Monterey Innovation Acquisition Corp. His 5 filings cover transactions from 2023-03-13 to 2025-04-29, with 0 EUR of buys and 3242 EUR of sells in the sampled recent filings, and the modal transaction nature is Attribution.